Radnor, Pennsylvania--(Newsfile Corp. - March 13, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Inari Medical, Inc. (NASDAQ: NARI) ("Inari Medical").
On February 28, 2024, during after-market hours, Inari Medical announced that the company had received a civil investigative demand from the U.S. Department of Justice concerning an investigation under the federal Anti-Kickback Statute and Civil False Claims Act related to specific payments made to healthcare professionals.
Following this news, Inari Medical's stock fell $12.14 per share, or 20.8%, to close at $46.12 on February 29, 2024.
If you are an Inari Medical investor and would like to learn more about our investigation, please CLICK HERE to fill out our online form or contact Kessler Topaz Meltzer & Check, LLP: Jonathan Naji, Esq. (484) 270-1453 or E-mail at info@ktmc.com. You can also click on the following link or paste it in your browser:https://www.ktmc.com/inari-medical-investigation?utm_source=PR&utm_medium=link&utm_campaign=nari&mktm=r
Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law. Kessler Topaz Meltzer & Check, LLP is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). For more information about Kessler Topaz Meltzer & Check, LLP, please visit www.ktmc.com.
CONTACT:
Kessler Topaz Meltzer & Check, LLP
Jonathan Naji, Esq.
280 King of Prussia Road
Radnor, PA 19087
(484) 270-1453
info@ktmc.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/201613
